Activity of Eribulin Mesylate in Brain Metastasis from Breast Cancer: A Stone in a Pond?

CONCLUSION: Our anecdotal experience suggests that eribulin may have a potentially beneficial effect on brain metastases while maintaining a good systemic control of the disease in patients with MBC.
PMID: 30041177 [PubMed - in process]

Source: Oncology - July 25, 2018 Category: Cancer & Oncology Authors: Catania G, Malaguti P, Gasparro S, Cognetti F, Vidiri A, Fabi A Tags: Oncology Source Type: research